The effect of Gamma and Ethylene Oxide Sterilization on a Selection of Active Pharmaceutical Ingredients for Ophthalmics.
Aciclovir
Dexamethasone
HPLC (high-performance/pressure liquid chromatography)
Methylprednisolone
Sterilization
Tetracycline hydrochloride
Triamcinolone
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
09
11
2021
revised:
13
01
2022
accepted:
13
01
2022
pubmed:
2
2
2022
medline:
22
6
2022
entrez:
1
2
2022
Statut:
ppublish
Résumé
Ensuring the sterility of life science products plays a pivotal role in the healthcare sector. Gamma irradiation and ethylene oxide sterilization are two commonly applied methods for the sterilization of medical devices, packaging components and Active Pharmaceutical Ingredients (API) for medicinal products. Focussed studies on the effects of sterilization processes on APIs remain limited. In this research study, five APIs, frequently used in sterile ophthalmic preparations were subjected to both gamma irradiation and ethylene oxide under different process conditions. The following APIs of GMP quality were selected: dexamethasone, aciclovir, tetracycline hydrochloride, triamcinolone and methylprednisolone. Analyses were performed using High Performance Liquid Chromatography equipped with UV detection and the effect of sterilization conditions on the APIs was evaluated by the assay and related substances test prescribed by the European Pharmacopoeia (Ph. Eur.). It was concluded that exposure to ethylene oxide resulted in compliance with Ph. Eur. for all APIs. While dexamethasone and methylprednisolone did not meet the requirement for the Ph. Eur. after exposure to gamma irradiation, the other three APIs did meet the requirement under the specified irradiation conditions. Subsequent optimization of sterilization parameters positively influenced the compliance to the Ph. Eur. requirements.
Identifiants
pubmed: 35101552
pii: S0022-3549(22)00031-4
doi: 10.1016/j.xphs.2022.01.020
pii:
doi:
Substances chimiques
Pharmaceutical Preparations
0
Dexamethasone
7S5I7G3JQL
Ethylene Oxide
JJH7GNN18P
Methylprednisolone
X4W7ZR7023
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2011-2017Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Sterigenics has no conflict of interest to disclose.